Literature DB >> 18684450

Interleukin-10 attenuates TNF-alpha-induced interleukin-6 production in endometriotic stromal cells.

Yukiko Tagashira1, Fuminori Taniguchi, Tasuku Harada, Ayako Ikeda, Ayako Watanabe, Naoki Terakawa.   

Abstract

OBJECTIVE: To determine whether high levels of interleukin (IL)-10 can attenuate the production of tumor necrosis factor (TNF)-alpha-induced proinflammatory cytokines in endometriotic stromal cells.
DESIGN: Prospective study.
SETTING: Department of Ob/Gyn, Tottori University, Japan. PATIENT(S): Thirty-five patients with ovarian endometrioma and ten patients with uterine myoma. INTERVENTION(S): Endometriotic stromal cells were obtained from chocolate cyst linings of ovaries. Endometrial stromal cells obtained from patient with uterine myoma. MAIN OUTCOME MEASURE(S): Expression of IL-10 gene in endometriotic or endometrial stromal cells was determined by real-time reverse-transcriptase polymerase chain reaction (RT-PCR). We performed immunohistochemical staining to find the presence of IL-10 and IL-10 receptors 1 and 2. We examined the effects of TNF-alpha and IL-10 on the expression of IL-6 or IL-8 by real-time RT-PCR and ELISA. We examined the activation of intracellular signal transduction molecules in endometriotic stromal cells by Western blotting. RESULT(S): Addition of IL-10 suppressed the expressions of IL-6 induced by TNF-alpha and IL-10 induced the phosphorylation of STAT3 in endometriotic stromal cells. TNF-alpha induced the expression of phosphorylated ERK1/2, JNK1/2, and I kappaB. Adding IL-10 suppressed the phosphorylation of these signal molecules. CONCLUSION(S): Interleukin-10 attenuates TNF-alpha-induced IL-6 synthesis via NF-kappaB and MAPK pathways in endometriotic cells.. Interleukin-10 may play a significant role in the pathogenesis of endometriosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18684450     DOI: 10.1016/j.fertnstert.2008.04.052

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

1.  MiR-199a attenuates endometrial stromal cell invasiveness through suppression of the IKKβ/NF-κB pathway and reduced interleukin-8 expression.

Authors:  Lan Dai; Liying Gu; Wen Di
Journal:  Mol Hum Reprod       Date:  2011-10-11       Impact factor: 4.025

2.  Targeted transcript analysis revealed association of suboptimal expression of certain endometrial immunity-related genes with disparate uterine diseases in zebu cows.

Authors:  R K Baithalu; S K Singh; A Kumaresan; S Kumar; B R Maharana; S Mallick; T K Mohanty; A K Mohanty
Journal:  Trop Anim Health Prod       Date:  2019-06-14       Impact factor: 1.893

3.  CD4+Foxp3+ regulatory T cell differentiation mediated by endometrial stromal cell-derived TECK promotes the growth and invasion of endometriotic lesions.

Authors:  M-Q Li; Y Wang; K-K Chang; Y-H Meng; L-B Liu; J Mei; Y Wang; X-Q Wang; L-P Jin; D-J Li
Journal:  Cell Death Dis       Date:  2014-10-02       Impact factor: 8.469

4.  PreImplantation Factor in endometriosis: A potential role in inducing immune privilege for ectopic endometrium.

Authors:  Marco Sbracia; Brett McKinnon; Fabio Scarpellini; Daniela Marconi; Gabriele Rossi; Cedric Simmilion; Michael D Mueller; Eytan R Barnea; Martin Mueller
Journal:  PLoS One       Date:  2017-09-13       Impact factor: 3.240

5.  HMGA2: A Biomarker in Gynecologic Neoplasia.

Authors:  Jian-Jun Wei
Journal:  J Clin Transl Pathol       Date:  2022-01-27

6.  Expression of genes associated with immunity in the endometrium of cattle with disparate postpartum uterine disease and fertility.

Authors:  Shan Herath; Sonia T Lilly; Natalia R Santos; Robert O Gilbert; Leopold Goetze; Clare E Bryant; John O White; James Cronin; I Martin Sheldon
Journal:  Reprod Biol Endocrinol       Date:  2009-05-29       Impact factor: 5.211

7.  The peritoneum is both a source and target of TGF-β in women with endometriosis.

Authors:  Vicky J Young; Jeremy K Brown; Philippa T K Saunders; W Colin Duncan; Andrew W Horne
Journal:  PLoS One       Date:  2014-09-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.